MLchartDataset catalogue

Jaypirca

Term · Oncology and biomedicine · MLC-T-ONC-004575

A drug used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or mantle cell lymphoma that was treated with at least two other types of therapy, including a BTK inhibitor. It is also being studied in the treatment of other types of cancer. Jaypirca blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called pirtobrutinib.

Table 1. Record
IdentifierMLC-T-ONC-004575
FieldOncology and biomedicine
Synonymspirtobrutinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004575",
  "term": "Jaypirca",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or mantle cell lymphoma that was treated with at least two other types of therapy, including a BTK inhibitor. It is also being studied in the treatment of other types of cancer. Jaypirca blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called pirtobrutinib.",
  "synonyms": [
    "pirtobrutinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/jaypirca/"
}

Record 9,684 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.